Could a drug delay menopause? scientists test Rapamycin's potential
NCT ID NCT05836025
Summary
This study is testing whether a low dose of the drug rapamycin can slow down ovarian aging in perimenopausal women. Researchers want to see if it can extend the reproductive window and delay menopause-related health changes. The trial involves 50 women aged 35-45 who will receive either rapamycin or a placebo for comparison.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIMENOPAUSAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University Irving Medical Center / NewYork-Presbyterian Hospital
New York, New York, 10032, United States
Conditions
Explore the condition pages connected to this study.